97 related articles for article (PubMed ID: 2372510)
1. Clinical and biochemical characterization of antithrombin III Franconville, a variant with Pro 41 Leu mutation.
de Roux N; Chadeuf G; Molho-Sabatier P; Plouin PF; Aiach M
Br J Haematol; 1990 Jun; 75(2):222-7. PubMed ID: 2372510
[TBL] [Abstract][Full Text] [Related]
2. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.
Okajima K; Ueyama H; Hashimoto Y; Sasaki Y; Matsumoto K; Okabe H; Inoue M; Araki S; Takatsuki K
Thromb Haemost; 1989 Feb; 61(1):20-4. PubMed ID: 2749590
[TBL] [Abstract][Full Text] [Related]
3. Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis.
Okajima K; Abe H; Maeda S; Motomura M; Tsujihata M; Nagataki S; Okabe H; Takatsuki K
Blood; 1993 Mar; 81(5):1300-5. PubMed ID: 8443391
[TBL] [Abstract][Full Text] [Related]
4. Homozygous variant of antithrombin III: AT III Fontainebleau.
Boyer C; Wolf M; Vedrenne J; Meyer D; Larrieu MJ
Thromb Haemost; 1986 Aug; 56(1):18-22. PubMed ID: 3775688
[TBL] [Abstract][Full Text] [Related]
5. Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin.
Okajima K; Abe H; Wagatsuma M; Okabe H; Takatsuki K
Am J Hematol; 1995 Jan; 48(1):12-8. PubMed ID: 7832187
[TBL] [Abstract][Full Text] [Related]
6. Antithrombin III Avranches, a new variant with defective serine-protease inhibition--comparison with antithrombin III Charleville.
Aiach M; Roncato M; Chadeuf G; Dezellus P; Capron L; Fiessinger JN
Thromb Haemost; 1988 Aug; 60(1):94-6. PubMed ID: 3187951
[TBL] [Abstract][Full Text] [Related]
7. Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.
Tripodi A; Krachmalnicoff A; Mannucci PM
Thromb Haemost; 1986 Dec; 56(3):349-52. PubMed ID: 3563966
[TBL] [Abstract][Full Text] [Related]
8. Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis.
Lane DA; Lowe GD; Flynn A; Thompson E; Ireland H; Erdjument H
Br J Haematol; 1987 Aug; 66(4):523-7. PubMed ID: 3663509
[TBL] [Abstract][Full Text] [Related]
9. An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy.
Aiach M; François D; Priollet P; Capron L; Roncato M; Alhenc-Gelas M; Fiessinger JN
Br J Haematol; 1987 Aug; 66(4):515-22. PubMed ID: 3663508
[TBL] [Abstract][Full Text] [Related]
10. Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity.
de Moerloose PA; Reber G; Vernet P; Minazio P; Bouvier CA
Thromb Haemost; 1987 Apr; 57(2):154-7. PubMed ID: 3603409
[TBL] [Abstract][Full Text] [Related]
11. Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").
Sambrano JE; Jacobson LJ; Reeve EB; Manco-Johnson MJ; Hathaway WE
J Clin Invest; 1986 Mar; 77(3):887-93. PubMed ID: 3512602
[TBL] [Abstract][Full Text] [Related]
12. Antithrombin "Chicago": a functionally abnormal molecule with increased heparin affinity causing familial thrombophilia.
Bauer KA; Ashenhurst JB; Chediak J; Rosenberg RD
Blood; 1983 Dec; 62(6):1242-50. PubMed ID: 6640109
[TBL] [Abstract][Full Text] [Related]
13. Antithrombin III Alger: a new homozygous AT III variant.
Fischer AM; Cornu P; Sternberg C; Mériane F; Dautzenberg MD; Chafa O; Beguin S; Desnos M
Thromb Haemost; 1986 Apr; 55(2):218-21. PubMed ID: 3715788
[TBL] [Abstract][Full Text] [Related]
14. Familial variant of antithrombin III (AT III Bligny, 47Arg to His) associated with protein C deficiency.
Wolf M; Boyer-Neumann C; Molho-Sabatier P; Neumann C; Meyer D; Larrieu MJ
Thromb Haemost; 1990 Apr; 63(2):215-9. PubMed ID: 2363123
[TBL] [Abstract][Full Text] [Related]
15. Antithrombin-III-Hamilton, Ala 382 to Thr: an antithrombin-III variant that acts as a substrate but not an inhibitor of alpha-thrombin and factor Xa.
Austin RC; Rachubinski RA; Ofosu FA; Blajchman MA
Blood; 1991 May; 77(10):2185-9. PubMed ID: 2029579
[TBL] [Abstract][Full Text] [Related]
16. Functional antithrombin-III variant (41 Pro----Leu) identified by liquid secondary ion mass spectrometry.
Brennan SO; Borg JY; Shaw GJ; Caen J; George PM
Pathology; 1991 Jan; 23(1):1-4. PubMed ID: 2062560
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
Jørgensen M; Petersen LC; Thorsen S
J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
[TBL] [Abstract][Full Text] [Related]
18. Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity.
Howarth DJ; Samson D; Stirling Y; Seghatchian MJ
Thromb Haemost; 1985 Jun; 53(3):314-9. PubMed ID: 4049307
[TBL] [Abstract][Full Text] [Related]
19. Homozygous or compound heterozygous qualitative antithrombin III deficiency.
Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A
Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):335-7. PubMed ID: 7971256
[TBL] [Abstract][Full Text] [Related]
20. Antithrombin Glasgow II: alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombin.
Ireland H; Lane DA; Thompson E; Walker ID; Blench I; Morris HR; Freyssinet JM; Grunebaum L; Olds R; Thein SL
Br J Haematol; 1991 Sep; 79(1):70-4. PubMed ID: 1911389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
